Benproperine Phosphate(CAS: 19428-14-9)

Benproperine Phosphate (CAS: 19428-14-9) is regulated under various guidelines. It should comply with the GHS classification for hazardous chemicals, including handling and storage guidelines. In the European Union, it must adhere to REACH regulations for the registration, evaluation, authorization, and restriction of chemicals. FDA and EPA regulations apply in the United States for its use in pharmaceuticals and environmental protection, respectively.

Alternatives to Benproperine Phosphate (CAS: 19428-14-9) in synthesis include other phosphoric acid derivatives such as isopropylmorphine phosphate, which serve similar functions. Common alternative reagents include other anilines and their derivatives, which can be used in place of Benproperine Phosphate depending on the specific reaction conditions and desired product.

The market for Benproperine Phosphate (CAS: 19428-14-9) is currently stable, with a focus on its use in pain management and its potential in developing new analgesic drugs. Research trends are shifting towards its efficacy in chronic pain treatment and the exploration of its mechanism of action. Market trends suggest increasing demand in the pharmaceutical industry, driven by rising healthcare costs and an aging population.

Waste containing Benproperine Phosphate (CAS: 19428-14-9) should be collected in appropriate containers and stored properly to prevent contamination. Incineration may be used for disposal, but it should be conducted in an approved facility to meet environmental standards. Alternatively, professional waste disposal services can handle the waste, ensuring compliance with environmental regulations and safety protocols.